XML 75 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Additional Financial Information of Parent Company - Financial Statements Schedule I (Table)
12 Months Ended
Dec. 31, 2022
Additional Financial Information of Parent Company - Financial Statements Schedule I  
Schedule of condensed balance sheet

As of December 31, 

2021

    

2022

2022

    

RMB

RMB

    

US$

Assets

 

  

 

  

Current assets

 

  

 

  

Cash and cash equivalents

 

224,145

349,845

 

50,723

Amounts due from related parties

 

760

823

 

119

Total current assets

 

224,905

350,668

 

50,842

Investments in subsidiaries and VIEs

 

8,538,829

9,636,776

 

1,397,199

Investments in affiliates

 

301,509

361,831

 

52,461

Other non-current assets

 

637

724

 

105

Total assets

 

9,065,880

10,349,999

 

1,500,607

Liabilities and Equity

 

 

  

Current liabilities

 

 

  

Contingent liabilities

 

433,345

469,018

 

68,001

Amounts due to subsidiaries and VIEs

575,428

467,178

67,734

Other current liabilities

 

16,332

8,107

 

1,175

Total liabilities

 

1,025,105

944,303

 

136,910

Shareholder’s equity

 

 

Ordinary shares (US$0.0005 par value): 91,394,900 Class A ordinary shares authorized, 22,683,970 shares issued and 21,764,455 shares outstanding as of December 31, 2021 and 100,000,000 ordinary shares authorized, 31,945,575 shares issued and 31,301,932 shares outstanding as of December 31, 2022

 

76

105

 

15

8,605,100 shares and nil Class B ordinary shares authorized, 8,315,000 and nil shares issued and outstanding as of December 31, 2021 and 2022, respectively

 

28

 

Treasury stock (919,515 and nil ordinary shares as of December 31, 2021 and 2022, respectively)

 

(541,379)

 

Additional paid-in capital

 

3,534,741

3,803,183

 

551,410

Retained earnings

 

5,187,323

5,604,954

 

812,642

Accumulated other comprehensive loss

 

(140,014)

(2,546)

 

(370)

Total shareholders’ equity

 

8,040,775

9,405,696

 

1,363,697

Total liabilities and shareholders’ equity

 

9,065,880

10,349,999

 

1,500,607

Schedule of condensed statements of operations

Year ended December 31, 

2020

2021

2022

2022

    

RMB

    

RMB

    

RMB

    

US$

Net revenues

 

 

 

 

Operating cost and expenses

 

 

 

 

Selling expenses

 

356

 

285

 

2,838

 

411

General and administrative expenses

 

5,588

 

41,955

 

16,948

 

2,457

Other operating expenses

12,516

1,815

Total operating cost and expenses

 

5,944

 

42,240

 

32,302

 

4,683

Loss from operations

 

(5,944)

 

(42,240)

 

(32,302)

 

(4,683)

Other income (expenses):

 

 

 

 

Interest income

 

20,545

 

2,266

 

4,250

 

616

Interest expenses

 

 

 

 

Settlement expenses

 

(1,828,907)

 

(19,908)

 

 

Other income (expenses)

 

14,713

 

(4,211)

 

11,083

 

1,607

Total other (expenses) income

 

(1,793,649)

 

(21,853)

 

15,333

 

2,223

Loss before taxes and income from equity in affiliates, subsidiaries and VIEs

 

(1,799,593)

 

(64,093)

 

(16,969)

 

(2,460)

Income tax expenses

 

(3,058)

 

 

 

Income from equity in affiliates

78,768

68,388

51,459

7,461

Income from equity in subsidiaries and VIEs

 

978,658

 

1,309,836

 

942,081

 

136,586

Net (loss) income

 

(745,225)

 

1,314,131

 

976,571

 

141,587

Schedule of Condensed statements of Comprehensive (Loss) income

    

Year ended December 31, 

2020

2021

2022

2022

    

RMB

    

RMB

    

RMB

    

US$

Net (loss) income

 

(745,225)

 

1,314,131

 

976,571

 

141,587

Other comprehensive (loss) income, net of tax

 

 

 

 

Foreign currency translation adjustments

 

(176,934)

 

(60,900)

 

137,468

 

19,932

Fair value fluctuation of available-for-sale investment, net of tax of nil

 

771

 

 

 

Total other comprehensive (loss) income, net of tax

 

(176,163)

 

(60,900)

 

137,468

 

19,932

Comprehensive (loss) income

 

(921,388)

 

1,253,231

 

1,114,039

 

161,519

Schedule of condensed statements of cash flow

Year ended December 31, 

2020

2021

2022

2022

    

RMB

    

RMB

    

RMB

    

US$

Cash flows from operating activities:

 

  

 

  

 

  

 

  

Net (loss) income

 

(745,225)

1,314,131

 

976,571

 

141,587

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Income from equity in subsidiaries and VIEs, net of dividends

 

(978,658)

(1,309,836)

 

(942,081)

 

(136,586)

Income from equity in affiliates, net of dividends

 

(58,913)

(28,606)

 

(41,385)

 

(6,000)

Share-based settlement expense

 

1,290,811

19,908

 

 

Changes in operating assets and liabilities:

 

Amounts due from subsidiaries and VIEs

 

356,685

 

 

Amounts due from related parties

 

(94)

18

 

(63)

 

(9)

Amounts due to subsidiaries and VIEs

56,937

28,584

52,262

7,577

Other current assets

 

(31,417)

40,772

 

 

Deferred tax assets

 

1,226

 

 

Contingent liabilities

 

530,433

(11,398)

 

 

Other current liabilities

 

(10,249)

11,828

 

(31,336)

 

(4,543)

Other non-current liabilities

 

908

(2,276)

 

 

Net cash provided by operating activities

 

412,444

63,125

 

13,968

 

2,026

Cash flows from investing activities:

 

 

 

Increase in investments in subsidiaries and VIEs

 

(43,690)

(1,120,785)

 

(17,492)

 

(2,536)

Capital return from investments in affiliates

 

101,114

 

 

Net cash provided by (used in) investing activities

 

57,424

(1,120,785)

 

(17,492)

 

(2,536)

Cash flows from financing activities:

Proceeds from issuance of ordinary shares upon exercise of stock options

33,372

11,114

1,493

216

Proceeds from advances from subsidiaries

537,604

287,876

41,738

Repayment of advances from subsidiaries

(82,481)

(448,387)

(65,010)

Payment for repurchase of ordinary shares

(281,610)

(372,376)

Proceeds from offering, net of issuance cost

247,015

35,814

Net cash (used in) provided by financing activities

(248,238)

93,861

87,997

12,758

Effect of exchange rate changes

(111,190)

(171,897)

41,227

5,977

Net increase (decrease) in cash and cash equivalents

 

110,440

(1,135,696)

 

125,700

 

18,225

Cash and cash equivalents - beginning of year

 

1,249,401

1,359,841

 

224,145

 

32,498

Cash and cash equivalents - end of year

 

1,359,841

224,145

 

349,845

 

50,723